HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 89 filers reported holding HARPOON THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.45 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,732 | +36.6% | 3,848 | +144.0% | 0.00% | – |
| Q3 2022 | $2,000 | – | 1,577 | +791.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 177 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 177 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 177 | +3.5% | 0.00% | – |
| Q3 2021 | $1,000 | -85.7% | 171 | -63.7% | 0.00% | – |
| Q2 2021 | $7,000 | -75.0% | 471 | -65.0% | 0.00% | – |
| Q1 2021 | $28,000 | – | 1,345 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 3,156,699 | $2,335,957 | 1.93% |
| MPM ASSET MANAGEMENT LLC | 3,131,388 | $2,329,753 | 0.97% |
| MPM BioImpact LLC | 3,196,707 | $2,378,350 | 0.62% |
| Lion Point Capital, LP | 169,283 | $125,980 | 0.05% |
| Artal Group S.A. | 1,000,000 | $744 | 0.04% |
| Cormorant Asset Management, LP | 540,600 | $402 | 0.03% |
| KENNEDY CAPITAL MANAGEMENT LLC | 529,934 | $394,377 | 0.01% |
| Orbimed Advisors | 621,218 | $462,310 | 0.01% |
| Tekla Capital Management LLC | 259,910 | $193,425 | 0.01% |
| CM WEALTH ADVISORS LLC | 50,354 | $29 | 0.01% |